Similar articles

• Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.

  Issels RD, Lindner LH, Verweij J, Wessalowski R, Reichardt P, Wust P, Ghadjar P, Hohenberger P, Angele M, Salat C, Vujaskovic Z, Daugaard S, Mella O, Mansmann U, Dürr HR, Knösel T, Abdel-Rahman S, Schmidt M, Hiddemann W, Jauch KW, Belka C, Gronchi A; European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society for Hyperthermic Oncology. Issels RD, et al. JAMA Oncol. 2018 Apr 1;4(4):483-492. doi: 10.1001/jamaoncol.2017.4996. JAMA Oncol. 2018. PMID: 29450452 Free PMC article. Clinical Trial.
• Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma.

  Sun R, Wei LJ. Sun R, et al. JAMA Oncol. 2019 Jan 1;5(1):112-113. doi: 10.1001/jamaoncol.2018.5287. JAMA Oncol. 2019. PMID: 30489612 No abstract available.
• Regional Hyperthermia With Neoadjuvant Chemotherapy for Treatment of Soft Tissue Sarcoma-Reply.

  Mansmann U, Lindner LH, Issels R. Mansmann U, et al. JAMA Oncol. 2019 Jan 1;5(1):114. doi: 10.1001/jamaoncol.2018.5293. JAMA Oncol. 2019. PMID: 30489599 No abstract available.
• [Systemic therapy and hyperthermia for locally advanced soft tissue sarcoma].

  Lindner LH, Angele M, Dürr HR, Rauch J, Bruns C. Lindner LH, et al. Chirurg. 2014 May;85(5):398-403. doi: 10.1007/s00104-013-2687-5. Chirurg. 2014. PMID: 24740176 Review. German.
• [Current state of neoadjuvant therapy of soft tissue sarcoma].

  Lehnhardt M, Schmitt T, Bischof M, Daigeler A, Egerer G. Lehnhardt M, et al. Chirurg. 2011 Nov;82(11):995-1000. doi: 10.1007/s00104-011-2132-6. Chirurg. 2011. PMID: 22008846 Review. German.